- Breast
- Lung
- Hematologic Oncology
- Gastrointestinal
- Genitourinary
- General Oncology
- Sarcoma
- Skin
- Head & Neck
- Event
Playback speed
10 seconds
Bone Marrow Allogenic Transplantation in Relapsed/ Refractory Hem Malignancies: IO Is Effective Bridging Strategy, and to Treat Relapses After HSCT, alloHSCT Technology Is Improving
By
Xth Eurasian Hematology-Oncology Congress
FEATURING
Ivan Moiseev
By
Xth Eurasian Hematology-Oncology Congress
FEATURING
Ivan Moiseev
11 views
December 13, 2019
Comments 0
Login to view comments.
Click here to Login
Hematologic Oncology